U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561216) titled 'Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars' on Feb. 18.
Brief Summary: This randomized clinical trial aims to evaluate and compare the clinical performance of injectable bioactive composite (Beautifil Flow Plus X, Shofu) versus Resin Modified Glass Ionomer (RMGI) in restoring proximal cavities (Class II) in primary molars of children aged 3-8 years over a 12-month follow-up period, using revised FDI criteria.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Dental Caries
Intervention:
OTHER: giomer
restoration of proximal cavities in primary molars using an injectable bioact...